Exploring Isolated Tumor Cells Entity In Endometrial Cancer
Vito Andrea Capozzi(University of Parma), Roberto Berretta(University of Parma), Marco Carnelli(Ospedale Papa Giovanni XXIII), Elisa Scarpelli(University of Parma), Giovanni Scambia(Agostino Gemelli University Polyclinic), Vincenzo Tarantino(Agostino Gemelli University Polyclinic), Andrea Puppo(Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo), Vito Chiàntera(University of Palermo), Marcello Ceccaroni(Clinical Orthopaedics and Related Research), Emanuele Perrone(Agostino Gemelli University Polyclinic), Pierandrea De Iaco(Clinical Orthopaedics and Related Research), Stefano Uccella(University of Insubria), Francesco Fanfani(Agostino Gemelli University Polyclinic), Giorgio Bogani(Fondazione IRCCS Istituto Nazionale dei Tumori)
Cited by 0
Related Papers
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
|New England Journal of Medicine|2018|2.9k
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2017|1.9k
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2021|412
Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta‐analysis
|Ultrasound in Obstetrics and Gynecology|2017|299